• norsk
    • English
  • English 
    • norsk
    • English
  • Login
View Item 
  •   Home
  • Øvrige samlinger
  • Publikasjoner fra CRIStin - NTNU
  • View Item
  •   Home
  • Øvrige samlinger
  • Publikasjoner fra CRIStin - NTNU
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

The ethics of access to patented biotech research tools from universities and other research institutions

Egelie, Knut Jørgen; Johansen, Berit; Strand, Sabina P.; Myskja, Bjørn Kåre
Journal article, Peer reviewed
Accepted version
Thumbnail
View/Open
Egelie (235.0Kb)
URI
http://hdl.handle.net/11250/2590769
Date
2018
Metadata
Show full item record
Collections
  • Institutt for biologi [2423]
  • Institutt for filosofi og religionsvitenskap [398]
  • Publikasjoner fra CRIStin - NTNU [35008]
Original version
Nature Biotechnology. 2018, 36 (6), 495-499.   10.1038/nbt.4165
Abstract
As universities and public research organizations increasingly partner with industry to fulfill their 'third mission' of innovation activities for economic and societal benefit, they have ethical obligations to ensure access to patented research tools, especially CRISPR–Cas9 technology.
Publisher
Nature Research (part of Springer Nature)
Journal
Nature Biotechnology

Contact Us | Send Feedback

Privacy policy
DSpace software copyright © 2002-2019  DuraSpace

Service from  Unit
 

 

Browse

ArchiveCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDocument TypesJournalsThis CollectionBy Issue DateAuthorsTitlesSubjectsDocument TypesJournals

My Account

Login

Statistics

View Usage Statistics

Contact Us | Send Feedback

Privacy policy
DSpace software copyright © 2002-2019  DuraSpace

Service from  Unit